NO136194C - Analogifremgangsm}te til fremstilling av terapeutisk virksomme gamma-piperidino-butyrofenonforbindelser. - Google Patents
Analogifremgangsm}te til fremstilling av terapeutisk virksomme gamma-piperidino-butyrofenonforbindelser.Info
- Publication number
- NO136194C NO136194C NO75753888A NO753888A NO136194C NO 136194 C NO136194 C NO 136194C NO 75753888 A NO75753888 A NO 75753888A NO 753888 A NO753888 A NO 753888A NO 136194 C NO136194 C NO 136194C
- Authority
- NO
- Norway
- Prior art keywords
- analogical
- piperidino
- procedures
- preparation
- therapeutically effective
- Prior art date
Links
- WLTFPYVGECWXFO-UHFFFAOYSA-N 1-phenyl-4-piperidin-1-ylbutan-1-one Chemical class C=1C=CC=CC=1C(=O)CCCN1CCCCC1 WLTFPYVGECWXFO-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO75753888A NO136194C (no) | 1969-07-16 | 1975-11-19 | Analogifremgangsm}te til fremstilling av terapeutisk virksomme gamma-piperidino-butyrofenonforbindelser. |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5660769 | 1969-07-16 | ||
| JP6214669A JPS504670B1 (no) | 1969-08-05 | 1969-08-05 | |
| JP44062479A JPS504671B1 (no) | 1969-08-06 | 1969-08-06 | |
| JP1940070 | 1970-03-07 | ||
| JP2372370 | 1970-03-20 | ||
| NO2776/70A NO133757C (no) | 1969-07-16 | 1970-07-15 | |
| NO75753888A NO136194C (no) | 1969-07-16 | 1975-11-19 | Analogifremgangsm}te til fremstilling av terapeutisk virksomme gamma-piperidino-butyrofenonforbindelser. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO753888L NO753888L (no) | 1971-01-18 |
| NO136194B NO136194B (no) | 1977-04-25 |
| NO136194C true NO136194C (no) | 1977-08-03 |
Family
ID=27563866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO75753888A NO136194C (no) | 1969-07-16 | 1975-11-19 | Analogifremgangsm}te til fremstilling av terapeutisk virksomme gamma-piperidino-butyrofenonforbindelser. |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO136194C (no) |
-
1975
- 1975-11-19 NO NO75753888A patent/NO136194C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO753888L (no) | 1971-01-18 |
| NO136194B (no) | 1977-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
| SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
| NO136459C (no) | Analogifremgangsm}te for fremstilling av antimikrobielt virksomme pleuromutiliner. | |
| NO140931C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme estere av alfa-aminobenzylpenicilliner | |
| SE383887B (sv) | Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner | |
| SE390304B (sv) | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin | |
| NO136045C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner. | |
| SE409708B (sv) | Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner | |
| NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
| NO773495L (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylalkylaminer | |
| NO147916C (no) | Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser. | |
| NO141755C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider | |
| NO139861C (no) | Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner | |
| SE402451B (sv) | Forfarande for framstellning av 14-desoxi-14-acetoximutilin | |
| NO136926C (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive papaverinanaloger | |
| NO136836C (no) | Fremgangsm}te til fremstilling av hydrokinon | |
| SE7505279L (sv) | Forfarande for framstellning av hydroxipyrimidiner. | |
| NO138364C (no) | Anordning til fremstilling av fiberarmerte plastroer | |
| NO138375C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater | |
| NO137093C (no) | Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner | |
| SE394668B (sv) | Forfarande for framstellning av 2-etylhexan-1-al | |
| NO136841C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner | |
| NO141851C (no) | Fremgangsmaate for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-n1.n4-dioksyd. | |
| NO139440C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-4h-pyraner | |
| SE411759B (sv) | Forfarande for framstellning av erytromycyliminforeningar |